c-Jun N-terminal kinase signaling in cellular senescence.
Ying DengVojtech AdamEugenie NepovimovaZbynek HegerMarian ValkoQinghua WuWei WeiKamil KucaPublished in: Archives of toxicology (2023)
Cellular senescence leads to decreased tissue regeneration and inflammation and is associated with diabetes, neurodegenerative diseases, and tumorigenesis. However, the mechanisms of cellular senescence are not fully understood. Emerging evidence has indicated that c-Jun N-terminal kinase (JNK) signaling is involved in the regulation of cellular senescence. JNK can downregulate hypoxia inducible factor-1α to accelerate hypoxia-induced neuronal cell senescence. The activation of JNK inhibits mTOR activity and triggers autophagy, which promotes cellular senescence. JNK can upregulate the expression of p53 and Bcl-2 and accelerates cancer cell senescence; however, this signaling also mediates the expression of amphiregulin and PD-LI to achieve cancer cell immune evasion and prevents their senescence. The activation of JNK further triggers forkhead box O expression and its target gene Jafrac1 to extend the lifespan of Drosophila. JNK can also upregulate the expression of DNA repair protein poly ADP-ribose polymerase 1 and heat shock protein to delay cellular senescence. This review discusses recent advances in understanding the function of JNK signaling in cellular senescence and includes a comprehensive analysis of the molecular mechanisms underlying JNK-mediated senescence evasion and oncogene-induced cellular senescence. We also summarize the research progress in anti-aging agents that target JNK signaling. This study will contribute to a better understanding of the molecular targets of cellular senescence and provides insights into anti-aging, which may be used to develop drugs for the treatment of aging-related diseases.
Keyphrases
- dna damage
- endothelial cells
- signaling pathway
- cell death
- stress induced
- dna repair
- induced apoptosis
- poor prognosis
- oxidative stress
- binding protein
- type diabetes
- stem cells
- high glucose
- cardiovascular disease
- metabolic syndrome
- dna methylation
- gene expression
- mouse model
- genome wide
- combination therapy
- smoking cessation
- protein kinase
- brain injury
- insulin resistance
- subarachnoid hemorrhage
- single molecule
- dna damage response